Auddia Inc. undergoes a stock split, Lixte Biotech advances precision oncology, American Fusion Inc. receives SEC approval, Sigyn Therapeutics introduces CardioDialysis, and grassroots opposition to data centers grows.
Auddia Inc. undergoes a stock split, Lixte Biotech advances precision oncology, American Fusion Inc. receives SEC approval, Sigyn Therapeutics introduces CardioDialysis, and grassroots opposition to data centers grows.